High expression of PGRMC1 in RCC tissue compared to adjacent non-cancerous tissues evinces its potential utility as a diagnostic and prognostic biomarker for RCC, as it has already demonstrated the ability to influence cancer cell susceptibility to chemotherapy, further emphasizing its correlation with tumour malignancy and progression.125. This evidence concerns the gene PGRMC1 and renal cell adenocarcinoma.